v3.26.1
Asset Acquisition (Details Narrative) - USD ($)
12 Months Ended
Sep. 29, 2025
Dec. 31, 2025
Dec. 31, 2024
Asset Acquisition [Line Items]      
Issuance of acquisition   $ 4,718,311  
Issuance of common share   7,006,982 $ 3,608,555
Shares adjusted value   4,683,099  
Unrealized gain recognized in other income   35,212
Value of stock issued   $ 6,714,512 $ 3,608,555
Telomir Pharmaceuticals Inc [Member]      
Asset Acquisition [Line Items]      
Issuance of acquisition 3,521,127    
Issuance of acquisition $ 5,000,000    
Share price $ 1.42    
SKNY Pharmaceuticals Inc [Member]      
Asset Acquisition [Line Items]      
Issuance of acquisition $ 4,718,311    
Share price $ 1.34    
Issuance of common share $ 4,718,310    
Issuance of shares 19,755,738    
New shares issued for value $ 26,275,132    
Share price $ 1.33    
Value of stock issued over net assets $ 4,718,310    
Value of stock issued 21,556,821    
Deemed dividend 21,556,821    
Increase to equity of common shares $ 4,718,311